Кредиторская задолженность Изменить Дата
Alaunos Therapeutics USD 613K 230K 2025-12
Amgen USD 19.52B 1.37B 2026-03
AstraZeneca USD 22.51B 2.78B 2026-03
Baxter International USD 1.09B 87M 2026-03
Biogen USD 358.5M 73.5M 2026-03
Bioline Rx USD 5.66M 2.2M 2025-09
Bristol-Myers Squibb USD 4.23B 659M 2026-03
Celltrion KRW 104.19B 15.67B 2025-09
Corcept Therapeutics USD 33.31M 7.14M 2026-03
Cspc Pharmaceutical CNY 2.32B 236.83M 2025-12
Curis USD 5.61M 1.52M 2025-12
Deva Holding AS TRY 809.81M 105.88M 2023-09
Dianthus Therapeutics USD 9.72M 3.02M 2025-12
Divis Laboratories Ltd INR 10.4B 1.3B 2025-09
Gilead Sciences USD 715M 93M 2025-12
GlaxoSmithKline GBP 14.34B 1.05B 2026-03
Incyte USD 228.62M 1.41B 2026-03
Intrexon USD 4.85M 3.12M 2024-06
Ionis Pharmaceuticals USD 26.03M 2.05M 2026-03
J&J USD 10.46B 1.53B 2026-03
Kangmei Pharma CNY 2.61B 176.42M 2025-09
Karyopharm Therapeutics USD 4M 1.39M 2025-12
Knight Therapeutics CAD 125.76M 7.63M 2025-12
Laboratorios Farma EUR 107.59M 341K 2023-12
Malin Corporation EUR 700K 200K 2024-12
Medical Developments International AUD 4.31M 2.18M 2025-12
Merck USD 4.4B 257M 2025-12
Neuren Pharmaceuticals AUD 2.4M 4.26M 2025-12
Novartis USD 4.46B 99M 2025-12
Organigram Holdings CAD 71.08M 18.17M 2025-12
Ovoca Bio EUR 186K 23K 2025-06
Pfizer USD 5.02B 142M 2025-09
Pharma Mar EUR 54.34M 10.54M 2025-12
PTC Therapeutics USD 45.49M 8.87M 2025-12
Qiagen NV USD 72.66M 2.11M 2025-12
Regeneron Pharmaceuticals USD 1.03B 4.81B 2026-03
Roche Holding CHF 5.78B 1.27B 2025-12
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sartorius EUR 345.3M 2.2M 2026-03
Sino Biopharmaceutical CNY 2.82B 1.32B 2025-06
TG Therapeutics USD 61.64M 72.38M 2025-09
Tilray USD 114.5M 3.69M 2025-09
Verastem USD 12.45M 2.56M 2025-12
Zealand Pharma A/S 346.6M 102.71M 2025-12
Zz Pientze Pharmaceu CNY 457.05M 59.09M 2026-03